Objective: To determine the frequency of depression and anxiety in carers of psychoactive substance use patients. Study Design: Cross sectional study Place and Duration of Study: Department of Psychiatry, Baluchistan Institute of Psychiatry & Behavioural Sciences, Quetta from June 2020 to December 2020. Methodology: One hundred and twenty caregivers of psychoactive substance use patients were enrolled. Detailed demographics of patients and caregivers were recorded after taking informed written consent. Patients were aged between 18-70 years. Depression and anxiety were calculated in primary caregivers of patients of psychoactive substance use. A DASS-21 criterion was used to examine the depression. Data was analysed by SPSS 22.0. Results: Mean age of patients was 35.27±15.43 years. 90 (75%) patients were males while 25% were females. Among caregivers 78 (65%) were females while 42 (35%) were males with mean age 36.86±16.48 years. Among caregivers, 12.5% of the patients had mild, 37.5% showed moderate and 18.33% caregivers showed severe depression while 38 (31.67%) had no depression. Anxiety among caregivers was mild in 12 (10%), 26 (21.7%) had moderate and 15 (12.5%) caregivers had severe anxiety while 67 (55.83%) caregivers had no anxiety. Conclusion: The frequency of anxiety and depression was high in primary caregivers of patients with psychoactive substance abuse. Keywords: Anxiety, Depression, Substance use, Caregivers
Objective: To determine the frequency of complications after electroconvulsive treatment in patients with schizophrenia. Study Design: Retrospective study Place and Duration of Study: Department of Psychiatry, Balochistan Institute of Psychiatry & Behavioural Sciences, Quetta 1st August 2020 to 31st March 2021. Methodology: One hundred and twenty patients of both genders were presented in this study. Patients were aged between 20-70years. Patient’s detailed demographics age, sex and mean body mass index were recorded after taking informed written consent. Patients of schizophrenia received electroconvulsive treatment. Frequency of immediate complications was observed after each session of electroconvulsive treatment and at the end of electroconvulsive treatment frequency of long term complications were observed. Results: Sixty five (54.17%) were males and 55 (45.83%) were females with mean age were 40.14±3.45 years and mean body mass index 22.14±6.12 kg/m2. Mean electroconvulsive treatment sessions was 88.13±6.87. Mean hospitalization stay was 3.4±2.04 weeks. Frequency of immediate complications were 25 (20.83%) among patients after electroconvulsive treatment session. Among 20.83%, frequency of body aches was 7 (8.83%), headache was in 11 (9.17%), frequency of transient amnesia was among 3 (2.5%) and hypertension was among 4 (3.33%). Significantly no any delay complications were observed in continuously sessions among enrolled cases. Conclusion: The use of electroconvulsive treatment sessions in patients of schizophrenia was effective because no any delay complications were observed in this treatment. Keywords: Schizophrenia, Electroconvulsive treatment (ECT), Treatment sessions
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.